About Polypeptide Laboratories Private Limited
Data last updated:
Polypeptide Laboratories Private Limited is a private limited company based in Ambernath, Maharashtra, India, a subsidiary of Polypeptide Laboratories Holding (Ppl) Ab. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 February 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2001PTC130734. Its GSTIN is 27AAGCP2809P1ZX (Maharashtra).
The company has an authorised share capital of ₹73.7 Cr and a paid-up capital of ₹60.38 Cr. It is led by directors including Juan Jose Gonzalez Casanova and Jens Fricke.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at K – 28 Additional MIDC Area Anand Nagar Ambernath (East), Maharashtra, India – 421506.
As per the financials filed for FY 2025, the company reported a revenue of ₹94.1 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹1.98 Cr (net margin 2.1%) and EBITDA of ₹18.61 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 20% over five years.
The company has about 108 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: PolyPeptide. Court records list 4 cases involving the company, including 4 filed by the company. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹57.87 Cr; the latest was in March 2019. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 3 smaller; the largest is Teena Labs Limited with revenue of ₹96.94 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website polypeptide.com.
Company details
Contact details
Polypeptide Laboratories Private Limited's registered office is in Ambernath, Maharashtra. Its website is polypeptide.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressK – 28 Additional MIDC Area Anand Nagar Ambernath (East), Maharashtra, India – 421506
- IndustryPharma, API Manufacturers
To see the full contact details of Polypeptide Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Polypeptide Laboratories operates one associated brand: PolyPeptide. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs. | polypeptide.com |
Business activity
The main business activity of Polypeptide Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Polypeptide Laboratories Private Limited, buy the company report.
Financials of Polypeptide Laboratories Private Limited
FY 2025 filings availablePolypeptide Laboratories Private Limited reported revenue of ₹94.1 Cr (up 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 34% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.61 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.98 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.8% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Polypeptide Laboratories Private Limited, buy the company report.
Board of directors of Polypeptide Laboratories Private Limited
Polypeptide Laboratories has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Juan Jose Gonzalez Casanova | Director | 28 Jun 2023 | 3 Years 3 Months | Current |
| Jens Fricke | Director | 01 Mar 2023 | 3 Years 7 Months | Current |
| Ashok Dattatraya Alate | Director | 06 Feb 2001 | 25 Years 8 Months | Current |
Peer comparison
Polypeptide Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Teena Labs Limited | ₹96.94 Cr (FY 2024) | -46.0% | Hyderabad, Telangana, India | |||
| B G P Healthcare Private Limited | ₹95.66 Cr (FY 2025) | -1.0% | Ankleshwar, Gujarat, India | |||
| Virupaksha Laboratories Private Limited | ₹94.74 Cr (FY 2024) | 12.0% | Hyderabad, Telangana, India | |||
| Aurore Pharmaceuticals Private Limited | ₹94.5 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Angels Pharma India Private Limited | ₹94.49 Cr (FY 2021) | 636.0% | Hyderabad, Telangana, India | |||
| Polypeptide Laboratories Private Limitedthis company | ₹94.1 Cr (FY 2025) | ₹1.98 Cr | 2.1% | 34.0% | 108 | Ambernath, Maharashtra, India |
| Integrin Lifesciences Private Limited | ₹92.04 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| Gennex Laboratories Limited | ₹91.62 Cr (FY 2024) | 32.0% | Medak, Telangana, India | |||
| Brichem Sciences Private Limited | ₹91.35 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Polypeptide Laboratories Private Limited, buy the company report.
Auditor
Polypeptide Laboratories Private Limited is audited by MS K A & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MS K A & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Polypeptide Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Polypeptide Laboratories Private Limited, buy the company report.
Deals & funding
Polypeptide Laboratories Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹57.87 Cr; the latest was in March 2019.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Polypeptide Laboratories Holdings PPL Seller: Poly Peptide Laboratories BV |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: Polypeptide Laboratories Holdings PPL, Polypeptide Laboratories Holdings PPL & Ashok Alate Seller: Poly Peptide Laboratories BV, Poly Peptide Laboratories BV & Ashok Alate |
| Sep 2010 | Funding round | ₹51.45 Cr | Investors: Poly Peptide Laboratories BV |
| Mar 2007 | Funding round | ₹6.42 Cr | Investors: Poly Peptide Laboratories BV |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Polypeptide Laboratories Private Limited has 4 court cases on record: 4 filed by Polypeptide Laboratories. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Central Board of Direct Taxes (Ministry of Revenue) and 2 Ors and 3 others | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Assistant Commissioner of Income Tax and 3 Other and 3 others | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Central Board of Direct Taxes and 2 Ors and 2 others | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Central Board of Direct Taxes (Ministry of Revenue) and 2 Ors. and 3 others | Disposed |
To see the full case history of Polypeptide Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Polypeptide Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Polypeptide Laboratories Private Limited has a workforce of 108 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Polypeptide Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCP2809P1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Polypeptide Laboratories Private Limited, buy the company report.
Recent activity
Polypeptide Laboratories Private Limited has 13 board changes on record since 2001: 3 appointments and 10 cessations. The latest: Jens Fricke ceased to be Additional Director on 29 Sep 2023.
4 earlier events are in the company report.
News
Frequently asked questions
Polypeptide Laboratories is an active private limited company based in Ambernath, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 February 2001 (25+ years old) and is registered under CIN U51397MH2001PTC130734.
Polypeptide Laboratories has 3 current directors:
- Juan Jose Gonzalez Casanova - Director
- Jens Fricke - Director
- Ashok Dattatraya Alate - Director
The latest financial statements of Polypeptide Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Polypeptide Laboratories is 27AAGCP2809P1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Polypeptide Laboratories is U51397MH2001PTC130734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Polypeptide Laboratories has 4 court cases on record: 4 filed by the company.
Polypeptide Laboratories was incorporated on 06 February 2001, making it 25+ years old. It is registered with the Registrar of Companies, Mumbai.
Polypeptide Laboratories has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹57.87 Cr; the latest was in March 2019.
The peers of Polypeptide Laboratories by revenue are Teena Labs Limited, B G P Healthcare Private Limited, Virupaksha Laboratories Private Limited, Aurore Pharmaceuticals Private Limited, Angels Pharma India Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jens Fricke ceased to be Additional Director on 29 Sep 2023. Juan Jose Gonzalez Casanova ceased to be Additional Director on 29 Sep 2023. Juan Jose Gonzalez Casanova was appointed as Director on 28 Jun 2023. Polypeptide Laboratories has 13 board changes on record in total.
Polypeptide Laboratories can be reached through the website polypeptide.com. Its registered office is in Ambernath, Maharashtra, India.